A BILL 
To substantially restrict the use of animal testing for 
cosmetics. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Humane Cosmetics 
4
Act of 2019’’. 
5
SEC. 2. ANIMAL TESTING. 
6
(a) PROHIBITION ON ANIMAL TESTING.—Beginning 
7
1 year after the date of enactment of this Act, it shall 
8
be unlawful for any person, whether private or govern-
9
03:28 Nov 27, 2019
H5141
2 
•HR 5141 IH
mental, to knowingly conduct or contract for cosmetic ani-
1
mal testing that occurs in the United States. 
2
(b) PROHIBITION ON SALE OR TRANSPORT.—It shall 
3
be unlawful to sell, offer for sale, or knowingly transport 
4
in interstate commerce in the United States any cosmetic 
5
that was developed or manufactured using cosmetic ani-
6
mal testing that was conducted or contracted for by any 
7
person in the cosmetic product’s supply chain after the 
8
date that is 1 year after the date of enactment of this 
9
Act. 
10
(c) DATA USE.— 
11
(1) IN
GENERAL.—No evidence derived from 
12
animal testing conducted after the effective date 
13
specified in subsection (a) may be relied upon to es-
14
tablish the safety of a cosmetic, cosmetic ingredient, 
15
or non-functional constituent under the Federal 
16
Food, Drug, and Cosmetic Act (21 U.S.C. 301 et 
17
seq.), unless— 
18
(A) in the case of such testing on an ingre-
19
dient or non-functional constituent, there is no 
20
non-animal alternative method or strategy rec-
21
ognized 
by 
any 
Federal 
agency 
or 
the 
22
Organisation for Economic Co-operation and 
23
Development for the relevant safety endpoints 
24
03:28 Nov 27, 2019
H5141
3 
•HR 5141 IH
for such ingredient or non-functional con-
1
stituent; and 
2
(B)(i) such animal testing is subject to an 
3
exemption under paragraph (2) or (3) of sub-
4
section (d); or 
5
(ii)(I) such animal testing is subject to an 
6
exemption under paragraph (4) of subsection 
7
(d); 
8
(II) there is documented evidence of the 
9
non-cosmetic intent of the test; and 
10
(III) there is a history of use of the ingre-
11
dient outside of cosmetics at least 1 year prior 
12
to the reliance on such data. 
13
(2) LIMITATION.—This section shall not be con-
14
strued to prohibit any entity from reviewing, assess-
15
ing, or retaining evidence generated from animal 
16
testing. 
17
(d) EXEMPTIONS.—Subsections (a) and (b) shall not 
18
apply with respect to animal testing— 
19
(1) conducted outside the United States in 
20
order to comply with a requirement from a foreign 
21
regulatory authority; 
22
(2) requested, required, or conducted by the 
23
Secretary, following— 
24
03:28 Nov 27, 2019
H5141
4 
•HR 5141 IH
(A) a written finding by the Secretary 
1
that— 
2
(i) there is no non-animal alternative 
3
method or strategy recognized by any Fed-
4
eral agency or the Organisation for Eco-
5
nomic Co-operation and Development for 
6
the relevant safety endpoints for the cos-
7
metic ingredient or non-functional con-
8
stituent; 
9
(ii) the cosmetic ingredient or non- 
10
functional constituent poses a risk of caus-
11
ing serious adverse health consequences or 
12
death; and 
13
(iii) the cosmetic ingredient or non- 
14
functional constituent is in wide use and, 
15
in the case of a cosmetic ingredient, cannot 
16
be replaced by another cosmetic ingredient 
17
capable of performing a similar function; 
18
(B) publication by the Secretary of the 
19
written finding required by subparagraph (A) 
20
on the internet website of the Food and Drug 
21
Administration together with a notice that the 
22
Secretary intends to request, require, or con-
23
duct new animal testing, and provides a period 
24
03:28 Nov 27, 2019
H5141
5 
•HR 5141 IH
of not less than 60 calendar days for public 
1
comment; and 
2
(C) a written determination by the Sec-
3
retary, after review of all public comments re-
4
ceived pursuant to subparagraph (B), that no 
5
previously generated data that could be sub-
6
stituted for, or otherwise determined sufficient 
7
to replace, the data expected to be produced 
8
through new animal testing is available for re-
9
view by the Secretary; 
10
(3) conducted for any product or ingredient 
11
that is subject to regulation under chapter V of the 
12
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
13
351 et seq.); or 
14
(4) conducted for non-cosmetic purposes pursu-
15
ant to a requirement of a Federal, State, or foreign 
16
regulatory authority. 
17
(e) RULE OF CONSTRUCTION.—With the exception of 
18
records or other information demonstrating compliance 
19
with subsection (c)(1)(B)(ii), nothing in this section shall 
20
be construed to authorize the Secretary to impose any new 
21
recordkeeping requirements relating to cosmetic animal 
22
testing. 
23
(f) CIVIL PENALTIES.— 
24
03:28 Nov 27, 2019
H5141
6 
•HR 5141 IH
(1) IN
GENERAL.—In addition to any other 
1
penalties applicable under law, the Secretary shall 
2
assess whoever violates any provision of this section 
3
a civil penalty of not more than $10,000 for each 
4
such violation. 
5
(2) MULTIPLE VIOLATIONS.—Each violation of 
6
this section with respect to a separate animal, and 
7
each day that a violation of this Act continues, con-
8
stitutes a separate offense. 
9
(g) RECORDS ACCESS.— 
10
(1) IN GENERAL.—The Secretary may request 
11
any records or other information from a cosmetic 
12
manufacturer that such manufacturer relied upon to 
13
meet the criteria in subsection (c)(1)(B)(ii). Such 
14
manufacturer shall, upon such request of the Sec-
15
retary in writing, provide to the Secretary such 
16
records or other information, within a reasonable 
17
timeframe, within reasonable limits, and in a reason-
18
able manner, and in either electronic or physical 
19
form, at the expense of such manufacturer. The Sec-
20
retary’s request shall include a sufficient description 
21
of the records requested and reference this sub-
22
section. 
23
(2) CONFIRMATION OF RECEIPT.—Upon receipt 
24
of the records requested under paragraph (1), the 
25
03:28 Nov 27, 2019
H5141
7 
•HR 5141 IH
Secretary shall provide to the manufacturer con-
1
firmation of receipt. 
2
(3) INSPECTION AUTHORITY.—Nothing in this 
3
subsection supplants the authority of the Secretary 
4
to conduct inspections otherwise permitted under the 
5
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
6
301 et seq.). 
7
(h) STATE AUTHORITY.—No State or political sub-
8
division of a State may establish or continue in effect any 
9
prohibition relating to cosmetic animal testing, or to the 
10
regulation of data use, labeling, and packaging related to 
11
animal testing, that is not identical to the prohibitions set 
12
forth in subsections (a), (b), (c), and (k) and that does 
13
not include the exemptions contained in subsections (c), 
14
(d), and (k). No State or political subdivision of a State 
15
may require any entity to perform cosmetic animal testing 
16
that is not permitted by subsection (a). 
17
(i) FDA STRATEGIC PLAN FOR NON-ANIMAL TEST 
18
METHODS.— 
19
(1) SCIENTIFIC INNOVATION.—To promote the 
20
development and provide for expedited review and 
21
acceptance of new scientifically valid test methods 
22
and strategies that are not based on vertebrate ani-
23
mals, the Secretary shall— 
24
03:28 Nov 27, 2019
H5141
8 
•HR 5141 IH
(A) not later than 1 year after the date of 
1
enactment of this Act, develop and publish on 
2
the internet website of the Food and Drug Ad-
3
ministration a strategic plan to promote the de-
4
velopment and implementation of alternative 
5
test methods and strategies to replace verte-
6
brate animal testing for assessing the safety of 
7
cosmetics; 
8
(B) provide a period of not less than 60 
9
calendar days for public comment regarding 
10
such strategic plan; 
11
(C) include in the strategic plan developed 
12
under subparagraph (A) a list, which the Sec-
13
retary shall update on a regular basis, of sci-
14
entifically reliable and relevant non-animal test 
15
methodology as alternatives to animal testing 
16
that have been recognized by any Federal agen-
17
cy or an international regulatory agency, which 
18
also includes next generation risk assessment 
19
methods, and a list of examples of alternative 
20
methods and strategies that have been accepted 
21
by the Secretary (such lists shall be for infor-
22
mation purposes and shall not be deemed to 
23
constitute a list of the only acceptable non-ani-
24
mal test methods); and 
25
03:28 Nov 27, 2019
H5141
9 
•HR 5141 IH
(D) to the maximum extent practicable 
1
with available resources, prioritize and carry 
2
out performance assessment, validation, and 
3
translational studies to accelerate the develop-
4
ment of scientifically valid test methods and 
5
strategies that replace the use of vertebrate ani-
6
mals. 
7
(2) PUBLIC MEETINGS.— 
8
(A) INITIAL MEETING.—No later than 90 
9
days after the date of enactment of this Act, 
10
the Secretary shall convene a public meeting re-
11
garding the strategic plan described in para-
12
graph (1)(A). 
13
(B) SUBSEQUENT
ANNUAL
MEETINGS.— 
14
No later than 1 year after the date of the pub-
15
lic meeting under subparagraph (A), and annu-
16
ally thereafter, the Secretary shall convene a 
17
public meeting to inform the Secretary’s ad-
18
vancement of alternative test methods and 
19
strategies to replace vertebrate animal testing 
20
for assessing the safety of cosmetics. The Sec-
21
retary shall include in such meetings scientific 
22
and academic experts, animal and consumer ad-
23
vocacy groups, and the regulated industry. 
24
03:28 Nov 27, 2019
H5141
10 
•HR 5141 IH
(3) RULE OF CONSTRUCTION.—Nothing in this 
1
subsection shall be construed to limit the authority 
2
of the Secretary to address other tools to promote 
3
the development and implementation of alternative 
4
test methods and strategies to replace vertebrate 
5
animal testing for assessing the safety of cosmetics 
6
as part of the strategic plan described in paragraph 
7
(1)(A). 
8
(j) DEFINITIONS.— 
9
(1) COSMETIC.—The term ‘‘cosmetic’’ has the 
10
meaning given such term in section 201(i) of the 
11
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
12
321(i)). 
13
(2) COSMETIC
ANIMAL
TESTING.—The term 
14
‘‘cosmetic animal testing’’ means the internal or ex-
15
ternal application or exposure of any cosmetic prod-
16
uct, or any cosmetic ingredient or non-functional 
17
constituent, to the skin, eyes, or other body part 
18
(organ or extremity) of a live non-human vertebrate 
19
for the purpose of evaluating the safety or efficacy 
20
of a cosmetic product or a cosmetic ingredient or 
21
non-functional constituent for use in a cosmetic 
22
product. 
23
03:28 Nov 27, 2019
H5141
11 
•HR 5141 IH
(3) LABEL.—The term ‘‘label’’ has the meaning 
1
given such term in section 201(k) of the Federal 
2
Food, Drug, and Cosmetic Act (21 U.S.C. 321(k)). 
3
(4) 
NON-FUNCTIONAL
CONSTITUENT.—The 
4
term ‘‘non-functional constituent’’ means any inci-
5
dental ingredient as defined in section 701.3(1) of 
6
title 21, Code of Federal Regulations, on the date of 
7
enactment of this section. 
8
(5) SECRETARY.—The term ‘‘Secretary’’ means 
9
the Secretary of Health and Human Services. 
10
(k) CONSUMER INFORMATION RELATED TO ANIMAL 
11
TESTING.— 
12
(1) IN GENERAL.—A cosmetic product manu-
13
facturer shall not include on the label of a cosmetic 
14
product or any of the product’s containers or wrap-
15
pers a claim that such cosmetic product was not 
16
tested on animals, including any claim or logo of 
17
‘‘cruelty free’’ if— 
18
(A) such cosmetic product or any ingre-
19
dient or non-functional constituent contained in 
20
such cosmetic product was tested on an animal 
21
after the effective date specified in subsection 
22
(a); and 
23
(B)(i) the testing was conducted by or con-
24
tracted for by the cosmetic product manufac-
25
03:28 Nov 27, 2019
H5141
12 
•HR 5141 IH
turer or another person in the supply chain at 
1
the direction or request of the cosmetic product 
2
manufacturer; or 
3
(ii) the cosmetic product manufacturer re-
4
lied upon evidence from such testing, pursuant 
5
to subsection (c)(1)(B)(ii), to establish the safe-
6
ty of such product, ingredient, or nonfunctional 
7
constituent under chapter VI of the Federal 
8
Food, Drug, and Cosmetic Act (21 U.S.C. 361 
9
et seq.). 
10
(2) EXCEPTIONS.—Notwithstanding paragraph 
11
(1), a cosmetic product manufacturer may include a 
12
claim described in such paragraph on the label of a 
13
cosmetic product described in such paragraph or any 
14
of the product’s containers or wrappers if— 
15
(A) such testing qualifies for the exemp-
16
tion under subsection (d)(4); and 
17
(B)(i) in the case of animal testing con-
18
ducted by or contracted for by the cosmetic 
19
product manufacturer or another person in the 
20
supply chain at the direction or request of the 
21
cosmetic product manufacturer, the cosmetic 
22
manufacturer did not rely upon evidence from 
23
such testing for the purpose of establishing the 
24
safety of the product, ingredient, or nonfunc-
25
03:28 Nov 27, 2019
H5141
13 
•HR 5141 IH
tional constituent under chapter VI of the Fed-
1
eral Food, Drug, and Cosmetic Act (21 U.S.C. 
2
361 et seq.); or 
3
(ii) in the case of animal testing conducted 
4
by or contracted for by a person that is not de-
5
scribed in clause (i), evidence from which the 
6
cosmetic product manufacturer relied upon, 
7
pursuant to subsection (c)(1)(B)(ii), to estab-
8
lish the safety of such product, ingredient, or 
9
nonfunctional constituent under chapter VI of 
10
the Federal Food, Drug, and Cosmetic Act (21 
11
U.S.C. 361 et seq.), the cosmetic product man-
12
ufacturer includes on the label a disclosure de-
13
scribing the circumstances surrounding the use 
14
of the exemption under subsection (c)(1)(B)(ii) 
15
by such manufacturer that includes a reference 
16
to the specific Federal, State, or foreign re-
17
quirement under which the animal testing was 
18
conducted or a reference to a publicly available 
19
internet website of such manufacturer that pro-
20
vides such disclosure. 
21
(l) REPORT.—Beginning 2 years after the date of en-
22
actment of this Act, the Secretary shall biennially submit 
23
to the Committee on Health, Education, Labor, and Pen-
24
sions of the Senate and the Committee on Energy and 
25
03:28 Nov 27, 2019
H5141
14 
•HR 5141 IH
Commerce of the House of Representatives, and make 
1
available on the internet website of the Food and Drug 
2
Administration, a report that includes, with respect to the 
3
previous 2 fiscal years— 
4
(1) updates on the Secretary’s implementation 
5
of this section, including developments implementing 
6
the strategic plan under subsection (i)(1)(A); 
7
(2) the number of times the Secretary re-
8
quested animal test data as set forth in subsection 
9
(d)(2), the ingredients involved, and the animal tests 
10
performed; and 
11
(3) based on the data reviewed by the Secretary 
12
under subsection (g)(1), the number of times manu-
13
facturers relied upon data pursuant to the exemp-
14
tion under subsection (d)(4) to establish the safety 
15
of a cosmetic under chapter VI of the Federal Food, 
16
Drug, and Cosmetic Act (21 U.S.C. 361 et seq.). 
17
Æ 
03:28 Nov 27, 2019
H5141
